Pharming Group NV - ADRPHAR
13F holders, Q2 2026 (June 30)16holders +3
5new positions
3sold out
1famous investor
$13.80avg. 13F price*
At the end of Q2 2026, 16 institutions reported holding Pharming Group NV - ADR (PHAR) in their 13F filings, up 3 from Q1 2026. 5 opened new positions and 3 sold out. The largest holders were Silverberg Bernstein Capital Management LLC ($577K), Crossmark Global Holdings, Inc. ($169K) and Citadel Advisors ($162K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Pharming Group NV - ADR
- CUSIP
- 71716E105
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 5 | $189K |
| Exits | 3 | $11K |
All 13F filers, Q1 2026 → Q2 2026: 15,707 shares bought and 6,761 shares sold, net +8,946 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 16 holders
| Silverberg Bernstein Capital Management LLC | 0.22% | Reduce -7.2% | 41,547 | $577K |
| Crossmark Global Holdings, Inc. | 0.00% | New | 12,463 | $169K |
| Citadel Advisors | 0.00% | Add +17.5% | 11,972 | $162K |
| Morgan Stanley | 0.00% | Add +0.1% | 11,500 | $160K |
| SmartHarvest Portfolios, LLC | 0.05% | Reduce -3.5% | 10,415 | $145K |
| Knoll Capital Management, LLC | 0.03% | Add +0.8% | 4,091 | $57K |
| Silver Grove Financial Group, Inc. | 0.01% | New | 1,071 | $15K |
| Nalls Sherbakoff Group, LLC | 0.01% | No change | 870 | $12K |
| Global Retirement Partners, LLC | 0.00% | — | 456 | $6K |
| BNP Paribas Financial Markets | 0.00% | Reduce -25.0% | 300 | $4K |
| Optiver Holding B.V. | 0.00% | New | 305 | $4K |
| NewEdge Advisors, LLC | 0.00% | Reduce -91.3% | 187 | $3K |
| UBS Group AG | 0.00% | New | 39 | $542 |
| Osaic Holdings, Inc. | 0.00% | Reduce -87.5% | 16 | $222 |
| Larson Financial Group LLC | 0.00% | Reduce -98.0% | 7 | $97 |
| Caitong International Asset Management Co., Ltd | 0.00% | New | 1 | $14 |
"% of holder's portfolio" is PHAR's weight in each manager's 13F, not the share of Pharming Group NV - ADR the manager owns.